RecruitingNCT04241328
Medtronic SYMBIOSIS Post-Market Registry for Patients Undergoing Cardiac Surgery
SYMBIOSIS Post-Market Registry
Sponsor
Medtronic Cardiac Surgery
Enrollment
5,000 participants
Start Date
Jan 9, 2020
Study Type
OBSERVATIONAL
Conditions
Summary
The purpose of this observational, multi-center prospective, post-market registry is to confirm real-world device safety and performance, to ensure the continued acceptability of identified risks, and detect emerging risks.
Eligibility
Inclusion Criteria2
- Subject or legally authorized representative provides written data release and/or informed consent per institution and/or geographical requirements prior to discharge from participating registry hospital.
- Subject will undergo or underwent a procedure in which an eligible Medtronic CS product is/was used.
Exclusion Criteria1
- Currently participating in an interventional drug or device study which may induce confounding factor(s) to the results from this Registry
Interested in this trial?
Get notified about updates and connect with the research team.
Locations(14)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT04241328
Related Trials
Diabetes and Heart Disease Risk in Blacks
NCT000018531 location
Moderate-Intensity Statin Plus Ezetimibe in CKD and ASCVD
NCT075241011 location
Biomedical Research Informatics Centre for Cardiovascular Sciences (The BRICCS Study)
NCT043889431 location
Human Observatory Study
NCT076467821 location
100-Year Human Aging Study
NCT075637771 location